Sponsors Face Misbranding for Failing to Conduct Pediatric Trials

Drug Industry Daily
KEYWORDS FDA / Trial
A A

Sponsors should conduct pediatric clinical trials as a means to both advance medical knowledge and avoid having products designated as misbranded, according to an industry expert.

To View This Article:

Login

Subscribe To Drug Industry Daily